ERNA · Ernexa Therapeutics Inc. · Fails to Deliver
$2.03
+0.04 (+1.85%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of June 30, 2026, the Company had approximately $5.0 million in cash, which is less than that needed to effect its current operating plan and forecasted cash requirements for the next twelve months. However, management expects that its ability to access capital under its ATM will cover shortfalls in its cash resources over the next twelve months from the issuance date of these financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$3.25M
Shares
1.63M
Volume · Oct 28
1591
Avg daily vol (3M)
51.78K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 3,124 | $3.11 | $9,716 |
| 2026-09-15 | 86 | $4.25 | $366 |
| 2026-09-11 | 7 | $4.02 | $28 |
| 2026-09-08 | 228 | $4.31 | $983 |
| 2026-09-03 | 866 | $4.54 | $3,932 |
| 2026-08-26 | 575 | $4.93 | $2,835 |
| 2026-08-24 | 1,440 | $4.86 | $6,998 |
| 2026-08-19 | 2,278 | $4.25 | $9,682 |
| 2026-08-12 | 1,740 | $4.39 | $7,639 |
| 2026-08-11 | 3,047 | $4.53 | $13,803 |
| 2026-08-10 | 6,297 | $4.21 | $26,510 |
| 2026-08-07 | 751 | $4.36 | $3,274 |
| 2026-08-05 | 3,808 | $4.42 | $16,831 |
Showing 1–13 of 13 settlements